Literature DB >> 22661673

Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis.

Tatsuhiro Yaginuma1, Izumi Yamamoto, Hiroyasu Yamamoto, Jun Mitome, Yudo Tanno, Keitaro Yokoyama, Takenori Hayashi, Tetsuya Kobayashi, Michiaki Watanabe, Yutaka Yamaguchi, Tatsuo Hosoya.   

Abstract

BACKGROUND: The angiogenic response is partly involved in the progression of encapsulating peritoneal sclerosis (EPS). However, the details of the angiogenic response, especially for lymphatic vessels in patients with EPS, remain unclear. In addition, because of technical limitations, morphology studies reported to date have examined only the parietal peritoneum. The morphologies of parietal and visceral lymphatic vessels in patients with EPS both need to be analyzed.
METHODS: We examined peritoneal samples from 18 patients with EPS who underwent enterolysis of the visceral peritoneum and compared them with samples from 17 autopsy cases (controls). To examine the angiogenic response, we performed immunohistochemistry for the endothelial markers CD34 (blood vessels) and podoplanin (lymphatic vessels) and for the cell proliferation marker Ki-67. Immunogold electron microscopy analysis for podoplanin was also performed. In 7 of 18 cases, we compared differences in the angiogenic response of the parietal and visceral peritoneal membranes.
RESULTS: Angiogenic responses were more frequent in the compact zone than in regenerated layers. The number of capillaries positive for anti-CD34 and anti-podoplanin monoclonal antibodies per unit area of visceral peritoneal tissue was, respectively, 41.1 ± 29.3/mm(2) in EPS patients and 2.7 ± 4.4/mm(2) in controls (p ≤ 0.01) and 48.1 ± 43.9/mm(2) in EPS patients and 4.1 ± 5.4/mm(2) in controls (p ≤ 0.01). The percentage of capillaries positive for anti-Ki-67, CD34, and podoplanin was 4.6% in EPS patients (p ≤ 0.01) and 0.8% in controls (p = 0.09). The immunogold electron microscopy analysis revealed that podoplanin was localized to endothelial cells with anchoring filaments, a specific feature of lymphatic vessels. Furthermore, compared with parietal peritoneal membrane, visceral peritoneal membrane had a more prominent podoplanin-positive capillary profile, but not a prominent CD34-positive capillary profile. In addition, fibroblast-like cells double-positive for podoplanin and smooth muscle actin were markedly increased in the degenerated layer, as previously reported.
CONCLUSIONS: Our study demonstrated that lymphatic vessels are increased in the visceral peritoneum of patients with EPS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661673      PMCID: PMC3524903          DOI: 10.3747/pdi.2011.00096

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  25 in total

1.  Molecular characterization of lymphatic endothelial cells.

Authors:  Simona Podgrabinska; Pascal Braun; Paula Velasco; Bryan Kloos; Michael S Pepper; Mihaela Skobe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-22       Impact factor: 11.205

2.  Pathology of encapsulating peritoneal sclerosis.

Authors:  Kazuho Honda; Hideaki Oda
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

Review 3.  Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment.

Authors:  Hidetomo Nakamoto
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

Review 4.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

5.  Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.

Authors:  Ester Martín-Villar; Diego Megías; Susanna Castel; Maria Marta Yurrita; Senén Vilaró; Miguel Quintanilla
Journal:  J Cell Sci       Date:  2006-10-17       Impact factor: 5.285

Review 6.  Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis.

Authors:  Rafael Selgas; Auxiliadora Bajo; José A Jiménez-Heffernan; Jose A Sánchez-Tomero; Gloria Del Peso; Abelardo Aguilera; Manuel López-Cabrera
Journal:  Nephrol Dial Transplant       Date:  2006-07       Impact factor: 5.992

7.  Use of nanogold followed by silver enhancement and gold toning for preembedding immunolocalization in osmium-fixed, Epon-embedded tissues.

Authors:  H Sawada; M Esaki
Journal:  J Electron Microsc (Tokyo)       Date:  1994-12

8.  Issues affecting the longevity of the continuous peritoneal dialysis therapy.

Authors:  Y Kawaguchi; T Hasegawa; M Nakayama; H Kubo; T Shigematu
Journal:  Kidney Int Suppl       Date:  1997-11       Impact factor: 10.545

9.  Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate.

Authors:  Miwako Numata; Masaaki Nakayama; Satoshi Nimura; Makio Kawakami; Bengt Lindholm; Yoshindo Kawaguchi
Journal:  Perit Dial Int       Date:  2003 Mar-Apr       Impact factor: 1.756

10.  Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models.

Authors:  Hiroaki Io; Chieko Hamada; Yuuki Ro; Yoshifumi Ito; Ichiro Hirahara; Yasuhiko Tomino
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

View more
  4 in total

1.  IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane.

Authors:  Rusan Catar; Janusz Witowski; Nan Zhu; Christian Lücht; Alicia Derrac Soria; Javier Uceda Fernandez; Lei Chen; Simon A Jones; Ceri A Fielding; Andras Rudolf; Nicholas Topley; Duska Dragun; Achim Jörres
Journal:  J Am Soc Nephrol       Date:  2016-11-11       Impact factor: 10.121

2.  Anthropometrics Identify Wasting in Patients Undergoing Surgery for Encapsulating Peritoneal Sclerosis.

Authors:  Rosalind Campbell; Titus Augustine; Helen Hurst; Ravi Pararajasingam; David van Dellen; Sheilagh Armstrong; Carol Bartley; Linda Birtles; Angela Summers
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

3.  Interstitial fibroblasts in donor kidneys predict late posttransplant anemia.

Authors:  Aki Mafune Hamada; Izumi Yamamoto; Mayuko Kawabe; Haruki Katsumata; Takafumi Yamakawa; Ai Katsuma; Yasuyuki Nakada; Akimitsu Kobayashi; Yusuke Koike; Jun Miki; Hiroki Yamada; Takahiro Kimura; Yudo Tanno; Ichiro Ohkido; Nobuo Tsuboi; Hiroyasu Yamamoto; Mitsuyoshi Urashima; Takashi Yokoo
Journal:  Clin Kidney J       Date:  2019-09-24

4.  The spectrum of podoplanin expression in encapsulating peritoneal sclerosis.

Authors:  Niko Braun; M Dominik Alscher; Peter Fritz; Joerg Latus; Ilka Edenhofer; Fabian Reimold; Seth L Alper; Martin Kimmel; Dagmar Biegger; Maja Lindenmeyer; Clemens D Cohen; Rudolf P Wüthrich; Stephan Segerer
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.